Verizon vs Johnson & Johnson: Which Dividend Hike Winner Is the Better Buy?
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Verizon (NYSE: VZ | VZ Price Prediction) and Johnson & Johnson (NYSE: JNJ) both rewarded shareholders with dividend increases this quarter, but their paths to sustaining those payouts look very different. Verizon raised its quarterly dividend to $0.69 per share, marking its 19th consecutive annual raise. Johnson & Johnson lifted its quarterly payout to $1.30 per share, extending a Dividend King streak spanning 63+ consecutive years. Verizon climbed 25.75% over the past month while Johnson & Johnson gained 11.28%.
Diverging Business Models, Different Dividend Foundations
Verizon’s telecom business generates steady cash but carries heavy infrastructure costs. The company produced $20.1 billion in free cash flow in 2025, covering its $11.5 billion dividend 1.75 times. That coverage is healthy, but a $158 billion debt load from the Frontier acquisition constrains flexibility. Capital expenditures consumed $17 billion, reflecting the capital-intensive nature of fiber and wireless infrastructure. CEO Dan Schulman said the company is “exiting 2025 with strong momentum” and promised Verizon “will no longer be a hunting ground for our competitors.” Wireless service revenue grew 1.1% year-over-year, though postpaid phone net adds of 616,000 were the highest quarterly total since 2019.
Johnson & Johnson operates a fundamentally different business. The healthcare giant generated $19.7 billion in free cash flow in 2025 while spending only $4.8 billion on capital expenditures, leaving room for $12.4 billion in dividends plus $6 billion in share buybacks. The payout ratio sits at a comfortable 62.8% of free cash flow. CEO Joaquin Duato called 2025 “a catapult year” driven by the “strongest portfolio and pipeline in our history.” Q4 revenue climbed 9.1% year-over-year to $24.56 billion, with oncology drugs like Darzalex and cardiovascular devices powering growth across Innovative Medicine and MedTech.
Yield Versus Growth: Two Paths Forward
Verizon offers a 5.8% dividend yield, more than double Johnson & Johnson’s 2.1%. But that income advantage has trade-offs. Verizon’s dividend has grown at a 2.04% annual rate over the past decade, barely outpacing inflation. Johnson & Johnson’s dividend expanded at a 4.7% annual clip over 27 years, with recent increases running 4% to 6% annually. Johnson & Johnson trades at 22x trailing earnings versus Verizon’s 12x, reflecting investor confidence in its innovation pipeline.
| Metric | Verizon | Johnson & Johnson |
| Dividend Yield | 5.8% | 2.1% |
| FCF Coverage | 1.75x | 1.59x |
| Total Debt | $158B | Lower (cleaner balance sheet) |
| 10-Year Dividend CAGR | 2.04% | ~4.7% |
Comparing Total Return Potential
Verizon’s 2026 free cash flow guidance of $21.5 billion suggests the payout is sustainable, though the $158 billion debt load and single-digit revenue growth limit upside. Johnson & Johnson’s 63-year track record survived multiple recessions without a cut, and projected EPS growth of 6.9% for 2026 could support continued dividend increases in the 4% to 6% range. Investors weighing the two will find Verizon offers higher current income while Johnson & Johnson has historically delivered faster dividend growth.
Contact [email protected] for any questions or corrections.







